Residual red blood cells in liquid plasma products: A quality assessment
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf036 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Furkan Yigitbilek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States. Hauptthemen laut MEDLINE: Erythrocytes, Plasma, Blood Preservation. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
Liquid plasma (LP) is an increasingly utilized blood product due to its immediate availability for transfusion without requiring thawing. While concerns exist regarding the presence of intact residual red blood cells (RBCs) in plasma products that have never been frozen, limited data are available on their levels in LP. This study aimed to evaluate residual RBC content in LP products to assess their safety for transfusion.
Methods
Liquid plasma units were prepared from whole-blood donations at the Stanford Blood Center. Seven group AB-positive, 1 group AB-negative, 10 group A-positive, and 2 group A-negative whole-blood units were collected in citrate phosphate dextrose anticoagulant, stored at 1 °C to 6 °C for 24 hours, centrifuged, and processed into LP. On day 2 of storage, 2-mL plasma samples were analyzed for RBC count, hemoglobin, and hematocrit.
Results
No residual RBCs were detected in any LP units, with all samples showing RBC counts below the limit of detection, hemoglobin levels of 0 g/dL, and hematocrit values of 0%. Given the uniform absence of RBC contamination, statistical analysis was not required.
Conclusions
The findings confirm that LP prepared under current blood processing standards contains no detectable residual RBCs, supporting its safety for transfusion with ABO-compatible products without the need for consideration of RhD compatibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
ORCID-Profile: Furkan Yigitbilek, Tho Pham
Zitieren
APA
Yigitbilek, F., Pandey, S., Pham, T., & Virk, M. S. (2025). Residual red blood cells in liquid plasma products: A quality assessment. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf036
Vancouver
Yigitbilek F, Pandey S, Pham T, Virk MS. Residual red blood cells in liquid plasma products: A quality assessment. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf036
BibTeX
@article{Yigitbilek2025,
author = {Yigitbilek, Furkan and Pandey, Suchitra and Pham, Tho and Virk, Mrigender Singh},
title = {Residual red blood cells in liquid plasma products: A quality assessment},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf036}
}
EUVIMED